Iridex (IRIX) EBITDA (2010 - 2026)

Iridex has reported EBITDA for 17 years, with the latest figure at -$1.0 million in Q3 2026.

• On a quarterly basis, EBITDA fell 9.47% year-over-year to -$1.0 million in Q3 2026; TTM through Jul 2026 was -$2.8 million, a 20.98% increase from a year earlier, with the FY2026 full-year figure at -$2.6 million, up 69.03% from the prior year.
• EBITDA was -$1.0 million for Q3 2026 at Iridex, down from -$324000.0 in the prior quarter.
• The five-year high for EBITDA was -$15000.0 in Q1 2026, with the low at -$3.3 million in Q1 2024.
• Average EBITDA over 5 years is -$1.6 million, with a median of -$1.7 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2026: EBITDA plunged 118.51% in 2023, then jumped 97.01% in 2026.
• Over 5 years, EBITDA stood at -$1.4 million in 2022, then slumped by 118.51% to -$3.1 million in 2023, then surged by 83.71% to -$502000.0 in 2024, then sank by 181.08% to -$1.4 million in 2025, then increased by 27.07% to -$1.0 million in 2026.
• The last three EBITDA figures came in at -$1.0 million (Q3 2026), -$324000.0 (Q2 2026), and -$15000.0 (Q1 2026), per Business Quant data.